The vaccine is expected to help control of Goat Pox disease in the country
Indian Immunologicals Limited (IIL), a leading vaccine manufacturer base out of Hyderabad, has launched ‘Goat Pox Vaccine (Raksha Goat Pox)’ for the significant Goat population in the country. Raksha Goat Pox vaccine is expected to help control of Goat Pox disease in the country, which has high economic importance among country’s rural livestock growers.
IIL’s Raksha Goat Pox vaccine is a live attenuated vaccine IP (Uttarkashi strain) grown on Vero Cell Culture. The Primary vaccination to be done at 3 months of age and revaccination annually with a dose rate of 1 ml, to be administered subcutaneously. The technology for vaccine manufacturing and testing of Goat Pox Vaccine was obtained from Indian Council of Agriculture Research – Indian Veterinary Research Institute (ICAR- IVRI), Government of India and has been tested and certified by IVRI for commercial release.
Speaking on the occasion from the launch, Managing Director of IIL, Dr K Anand Kumar said, “Indian Immunologicals is committed to introducing such products for the national interest and will abundantly help marginal livestock growers of their livelihood and protect their flock from various diseases“. Dr Priyabrata Pattnaik, Deputy Managing Director and Sobhan Babu, Vice President – Animal Health Trade of IIL were also present in the Goat Pox Vaccine launch event.
Earlier IIL launched several other vaccines such as Classical Swine Fever vaccine, PPR Vaccine etc under tech transfer arrangement with IVRI.
